Loading clinical trials...
Loading clinical trials...
Patients with acute leukemia or received SCT are hospitalized in protected area, at least for 28 days. In this area, there is some rules like: controlled-visit, protective-clothing….so patient are in ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Lille
NCT06390319 · T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, and more
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07216443 · Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and more
NCT07295951 · Acute Lymphoblastic Leukemia, Acute Leukemias, and more
NCT04726241 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and more
University Hospital
Lille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions